World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   55573 records for 22205 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of Registration
AuthorisedYesEUCTR2016-004942-27-FR
Study of Inotuzumab Ozogamicin (INO) Combined to Chemotherapy in Older Patients with Philadelphia Chromosome-negative CD22+ B-cell Precursor Acute Lymphoblastic Leukemia
21/07/2017
RecruitingYesNCT03225924
Study of Entospletinib (ENTO) in Newly Diagnosed DLBCL Patients With aaIPI>=1 Treated by Chemiotherapy
20/07/2017
Not recruitingYesNCT03225378
Changes in PPV Induced by PLR Test to Predict Fluid Responsiveness in ICU
20/07/2017
Not recruitingYesNCT03222947
New Variants Involved in Taybi-Linder Syndrome
18/07/2017
Not recruitingYesNCT03223090
Motor Language Learning
18/07/2017
Not AvailableYesEUCTR2016-003191-50-DK
A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991 18/07/2017
Not AvailableYesEUCTR2016-000951-29-FR
A research study of a new investigational medicinal product for the treatment of young Duchenne Muscular Dystrophy patients
17/07/2017
Not recruitingYesNCT03221426
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)
17/07/2017
Not recruitingYesNCT03221634
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668)
17/07/2017
RecruitingNoNCT03225027
Study on Communication Comprehension in the Schizophrenic Spectrum
17/07/2017
     
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.3 - Version history